Accès gratuit
Numéro
Med Sci (Paris)
Volume 26, Numéro 5, Mai 2010
Page(s) 505 - 515
Section M/S revues
DOI https://doi.org/10.1051/medsci/2010265509
Publié en ligne 15 mai 2010
  1. Seddon JM, Ajani UA, Mitchell BD. Familial aggregation of age-related maculopathy. Am J Ophthalmol 1997; 123 : 199–206. [Google Scholar]
  2. Klaver CC, Wolfs RC, Assink JJ, et al. Genetic risk of age-related maculopathy. Population-based familial aggregation study. Arch Ophthalmol 1998; 116 : 1646–51. [Google Scholar]
  3. Klein BE, Klein R, Lee KE, et al. Risk of incident age-related eye diseases in people with an affected sibling: The Beaver Dam Eye study. Am J Epidemiol 2001; 154 : 207–11. [Google Scholar]
  4. Assink JJ, Klaver CC, Houwing-Duistermaat JJ, et al. Heterogeneity of the genetic risk in age-related macular disease: a population-based familial risk study. Ophthalmology 2005; 112 : 482–7. [Google Scholar]
  5. Luo L, Harmon J, Yang X, et al. Familial aggregation of age-related macular degeneration in the Utah population. Vision Res 2008; 48 : 494–500. [Google Scholar]
  6. Seddon JM, Cote J, Page WF, et al. The US twin study of age-related macular degeneration: relative roles of genetic and environmental influences. Arch Ophthalmol 2005; 123 : 321–7. [Google Scholar]
  7. Souied EH, Benlian P, Amouyel P, et al. The epsilon4 allele of the apolipoprotein E gene as a potential protective factor for exudative age-related macular degeneration. Am J Ophthalmol 1998; 125 : 353–9. [Google Scholar]
  8. Klaver CC, Kliffen M, van Duijn CM, et al. Genetic association of apolipoprotein E with age-related macular degeneration. Am J Hum Genet 1998; 63 : 200–6. [Google Scholar]
  9. Thakkinstian A, Bowe S, McEvoy M, et al. Association between apolipoprotein E polymorphisms and age-related macular degeneration: A HuGE review and meta-analysis. Am J Epidemiol 2006; 164 : 813–22. [Google Scholar]
  10. Allikmets R, Shroyer NF, Singh N, et al. Mutation of the Stargardt disease gene (ABCR) in age-related macular degeneration. Science 1997; 277 : 1805–7. [Google Scholar]
  11. Stone EM, Webster AR, Vandenburgh K, et al. Allelic variation in ABCR associated with Stargardt disease but not age-related macular degeneration. Nat Genet 1998; 20 : 328–9. [Google Scholar]
  12. Allikmets R. Further evidence for an association of ABCR alleles with age-related macular degeneration. The International ABCR Screening Consortium. Am J Hum Genet 2000; 67 : 487–91. [Google Scholar]
  13. Baudouin C, Peyman GA, Fredj-Reygrobellet D, et al. Immunohistological study of subretinal membranes in age-related macular degeneration. Jpn J Ophthalmol 1992; 36 : 443–51. [Google Scholar]
  14. Hageman GS, Luthert PJ, Victor Chong NH, et al. An integrated hypothesis that considers drusen as biomarkers of immune-mediated processes at the RPE-Bruch’s membrane interface in aging and age-related macular degeneration. Prog Retin Eye Res 2001; 20 : 705–32. [Google Scholar]
  15. Klein RJ, Zeiss C, Chew EY, et al. Complement factor H polymorphism in age-related macular degeneration. Science 2005; 308 : 385–9. [Google Scholar]
  16. Souied EH, Leveziel N, Richard F, et al. Y402H complement factor H polymorphism associated with exudative age-related macular degeneration in the French population. Mol Vis 2005; 11 : 1135–40. [Google Scholar]
  17. Gotoh N, Yamada R, Hiratani H, et al. No association between complement factor H gene polymorphism and exudative age-related macular degeneration in Japanese. Hum Genet 2006; 120 : 139–43. [Google Scholar]
  18. Thakkinstian A, Han P, McEvoy M, et al. Systematic review and meta-analysis of the association between complement factor H Y402H polymorphisms and age-related macular degeneration. Hum Mol Genet 2006; 15 : 2784–90. [Google Scholar]
  19. Seddon JM, Santangelo SL, Book K, et al. A genomewide scan for age-related macular degeneration provides evidence for linkage to several chromosomal regions. Am J Hum Genet 2003; 73 : 780–90. [Google Scholar]
  20. Jakobsdottir J, Conley YP, Weeks DE, et al. Susceptibility genes for age-related maculopathy on chromosome 10q26. Am J Hum Genet 2005; 77 : 389–407. [Google Scholar]
  21. Rivera A, Fisher SA, Fritsche LG, et al. Hypothetical LOC387715 is a second major susceptibility gene for age-related macular degeneration, contributing independently of complement factor H to disease risk. Hum Mol Genet 2005; 14 : 3227–36. [Google Scholar]
  22. Chien J, Staub J, Hu SI, et al. A candidate tumor suppressor HtrA1 is downregulated in ovarian cancer. Oncogene 2004; 23 : 1636–44. [Google Scholar]
  23. Dewan A, Liu M, Hartman S, et al. HTRA1 promoter polymorphism in wet age-related macular degeneration. Science 2006; 314 : 989–92. [Google Scholar]
  24. Chen W, Xu W, Tao Q, et al. Meta-analysis of the association of the HTRA1 polymorphisms with the risk of age-related macular degeneration. Exp Eye Res 2009; 89 : 292–300. [Google Scholar]
  25. Kanda A, Chen W, Othman M, et al. A variant of mitochondrial protein LOC387715/ARMS2, not HTRA1, is strongly associated with age-related macular degeneration. Proc Natl Acad Sci USA 2007; 104 : 16227–32. [Google Scholar]
  26. Dewan A, Liu M, Hartman S, et al. HTRA1 promoter polymorphism in wet age-related macular degeneration. Science 2006; 314 : 989–92. [Google Scholar]
  27. Yang Z, Camp NJ, Sun H, et al. A variant of the HTRA1 gene increases susceptibility to age-related macular degeneration. Science 2006; 314 : 992–3. [Google Scholar]
  28. Fritsche LG, Loenhardt T, Janssen A, et al. Age-related macular degeneration is associated with an unstable ARMS2 (LOC387715) mRNA. Nat Genet 2008; 40 : 892–6. [Google Scholar]
  29. Conley YP, Jakobsdottir J, Mah T, et al. CFH, ELOVL4, PLEKHA1 and LOC387715 genes and susceptibility to age-related maculopathy: AREDS and CHS cohorts and meta-analyses. Hum Mol Genet 2006; 15 : 3206–18. [Google Scholar]
  30. Seddon JM, Francis PJ, George S, et al. Association of CFH Y402H and LOC387715 A69S with progression of age-related macular degeneration. JAMA 2007; 297 : 1793–800. [Google Scholar]
  31. Seddon JM, Reynolds R, Maller J, et al. Prediction model for prevalence and incidence of advanced age-related macular degeneration based on genetic, demographic, and environmental variables. Invest Ophthalmol Vis Sci 2009; 50 : 2044–53. [Google Scholar]
  32. Haddad WM, Coscas G, Soubrane G. Eligibility for treatment and angiographic features at the early stage of exudative age related macular degeneration. Br J Ophthalmol 2002; 86 : 663–9. [Google Scholar]
  33. Cohen SY, Creuzot-Garcher C, Darmon J, et al. Types of choroidal neovascularization (CNV) in newly diagnosed exudative age-related macular degeneration (AMD). Br J Ophthalmol 2007; 91 : 1173–6. [Google Scholar]
  34. Leveziel N, Zerbib J, Richard F, et al. Genotype-phenotype correlation for exudative age-related macular degeneration associated with homozygous HTRA1 and CFH genotypes. Invest Ophthalmol Vis Sci 2008; 49 : 3090–4. [Google Scholar]
  35. Wegscheider BJ, Weger M, Renner W, et al. Association of complement factor H Y402H gene polymorphism with different subtypes of exudative age-related macular degeneration. Ophthalmology 2007; 114 : 738–42. [Google Scholar]
  36. Droz I, Mantel I, Ambresin A, et al. Genotype-phenotype correlation of age-related macular degeneration: influence of complement factor H polymorphism. Br J Ophthalmol 2008; 92 : 513–7. [Google Scholar]
  37. Leveziel N, Puche N, Richard F, et al. Genotypic influences on severity of exudative age-related macular degeneration. Invest Ophthalmol Vis Sci 2010 (sous presse). [Google Scholar]
  38. Sakurada Y, Kubota T, Imasawa M, et al. Angiographic lesion size associated with LOC387715 A69S genotype in subfoveal polypoidal choroidal vasculopathy. Retina 2009; 29 : 1522–6. [Google Scholar]
  39. Klein ML, Francis PJ, Rosner B, et al. CFH and LOC387715/ARMS2 Genotypes and Treatment with Antioxidants and Zinc for Age-Related Macular Degeneration. Ophthalmology 2008; 115 : 1019–25. [Google Scholar]
  40. Rosenfeld PJ, Brown DM, Heier JS, et al. MARINA Study Group. Ranibizumab for neovascular age-related macular degeneration. N Engl J Med 2006; 355 : 1419–31. [Google Scholar]
  41. Brown DM, Kaiser PK, Michels M, et al. Comparison of ranibizumab and verteporfin photodynamic therapy for neovascular age-related macular degeneration. N Engl J Med 2006; 355 : 1432–14. [Google Scholar]
  42. Brantley MA Jr, Fang AM, King JM, et al. Association of complement factor H and LOC387715 genotypes with response of exudative age-related macular degeneration to intravitreal bevacizumab. Ophthalmology 2007; 114 : 2168–73. [Google Scholar]
  43. Leveziel N, Soubrane G, H Souied E. Anti-VEGF : applications pratiques en ophtalmologie. Med Sci (Paris) 2009; 25 : 1105–7. [Google Scholar]
  44. Brantley MA Jr, Edelstein SL, King JM, et al. Association of complement factor H and LOC387715 genotypes with response of exudative age-related macular degeneration to photodynamic therapy. Eye (Londres) 2009; 23 : 626–31. [Google Scholar]
  45. Lin JM, Wan L, Tsai YY, et al. Vascular endothelial growth factor gene polymorphisms in age-related macular degeneration. Am J Ophthalmol 2008; 145 : 1045–51. [Google Scholar]
  46. Haines JL, Schnetz-Boutaud N, Schmidt S, et al. Functional candidate genes in age-related macular degeneration: significant association with VEGF, VLDLR, and LRP6. Invest Ophthalmol Vis Sci 2006; 47 : 329–335. [Google Scholar]
  47. Churchill AJ, Carter JG, Lovell HC, et al. VEGF polymorphisms are associated with neovascular age-related macular degeneration. Hum Mol Genet 2006; 15 : 2955–61. [Google Scholar]
  48. Behar-Cohen F, Sennlaub F, Berdugo M. Espoirs thérapeutiques dans la DMLA. Med Sci (Paris) 2007; 23 : 127–9. [Google Scholar]

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.